Recruiting

Observational Study

Sponsor:

Michael Tomasson

Code:

NCT04115241

Conditions

Bone Marrow Transplant

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Actigraph

Grip strength test

Study Details

Brief summary:

Participants in this study will be receiving a bone marrow transplant. This study is designed to evaluate correlations between activity levels and length of stay, quality of life, and hand grip strength.

Conditions

Bone Marrow Transplant

Study ID

NCT04115241

Start date

May 23, 2019

Status verified date

Nov, 2025

Completion date

May 23, 2030

Anticipated

Primary completion date

May 23, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Patients who will be receiving a bone marrow transplant are eligible for this study

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Interventions

Actigraph

Actigraphs are non-invasive, wearable devices that measure activity levels using an accelerometer

Grip strength test

The purpose of this test is to measure the maximum isometric strength of the hand and forearm muscles

Primary outcome measure

  • To determine the correlation between activity levels and length of stay in hospital [ Time Frame: From study intitiation for up to 5 years ]
  • To determine the correlation between activity levels and quality of life [ Time Frame: From study intitiation for up to 5 years ]
  • To determine the correlation between activity levels and hand grip strength [ Time Frame: From study intitiation for up to 5 years ]

Central Contacts and Locations

Central contacts

Locations

University of Iowa

Recruiting

Iowa City, Iowa, United States, 52242

Contacts

More Information

Sponsor

Michael Tomasson

Last update posted

Nov 10, 2025

Last verified

Nov, 2025

Keywords

  • leukemia
  • multiple myeloma
  • myelodysplastic syndrome
  • stem cell transplant

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Michael Tomasson on 2025-11-10.